Citigroup’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.31M Sell
77,951
-43,893
-36% -$2.43M ﹤0.01% 1513
2025
Q1
$5.89M Buy
121,844
+822
+0.7% +$39.8K ﹤0.01% 1276
2024
Q4
$4.67M Buy
121,022
+47,532
+65% +$1.83M ﹤0.01% 1468
2024
Q3
$3.31M Buy
73,490
+52,475
+250% +$2.36M ﹤0.01% 1646
2024
Q2
$728K Sell
21,015
-187,626
-90% -$6.5M ﹤0.01% 2456
2024
Q1
$6.04M Buy
208,641
+135,938
+187% +$3.93M ﹤0.01% 1142
2023
Q4
$1.67M Sell
72,703
-75,125
-51% -$1.72M ﹤0.01% 1781
2023
Q3
$2.47M Buy
147,828
+40,307
+37% +$672K ﹤0.01% 1366
2023
Q2
$2.97M Sell
107,521
-84,828
-44% -$2.34M ﹤0.01% 1414
2023
Q1
$4.42M Buy
192,349
+44,281
+30% +$1.02M ﹤0.01% 1165
2022
Q4
$1.62M Sell
148,068
-167,126
-53% -$1.82M ﹤0.01% 1670
2022
Q3
$2.66M Sell
315,194
-2,305
-0.7% -$19.4K ﹤0.01% 1432
2022
Q2
$2.51M Buy
317,499
+281,843
+790% +$2.23M ﹤0.01% 1449
2022
Q1
$844K Sell
35,656
-102,095
-74% -$2.42M ﹤0.01% 2487
2021
Q4
$4.71M Buy
137,751
+86,566
+169% +$2.96M ﹤0.01% 1325
2021
Q3
$907K Sell
51,185
-21,355
-29% -$378K ﹤0.01% 2461
2021
Q2
$3.26M Sell
72,540
-23,180
-24% -$1.04M ﹤0.01% 1746
2021
Q1
$2.48M Buy
95,720
+86,013
+886% +$2.23M ﹤0.01% 1812
2020
Q4
$196K Buy
9,707
+7,296
+303% +$147K ﹤0.01% 3253
2020
Q3
$47K Sell
2,411
-62,136
-96% -$1.21M ﹤0.01% 3525
2020
Q2
$1.14M Buy
64,547
+57,525
+819% +$1.02M ﹤0.01% 2008
2020
Q1
$50K Buy
7,022
+1,383
+25% +$9.85K ﹤0.01% 3790
2019
Q4
$40K Buy
5,639
+4,942
+709% +$35.1K ﹤0.01% 4111
2019
Q3
$8K Sell
697
-3,410
-83% -$39.1K ﹤0.01% 4650
2019
Q2
$50K Sell
4,107
-21,244
-84% -$259K ﹤0.01% 4095
2019
Q1
$319K Buy
+25,351
New +$319K ﹤0.01% 2812
2018
Q3
Sell
-12,697
Closed -$85K 5107
2018
Q2
$85K Buy
12,697
+10,702
+536% +$71.6K ﹤0.01% 3538
2018
Q1
$17K Buy
1,995
+245
+14% +$2.09K ﹤0.01% 4298
2017
Q4
$36K Buy
+1,750
New +$36K ﹤0.01% 3968
2017
Q3
Sell
-63
Closed -$1K 4827
2017
Q2
$1K Sell
63
-81
-56% -$1.29K ﹤0.01% 4735
2017
Q1
$2K Sell
144
-7,500
-98% -$104K ﹤0.01% 4648
2016
Q4
$168K Buy
7,644
+7,023
+1,131% +$154K ﹤0.01% 3673
2016
Q3
$13K Buy
+621
New +$13K ﹤0.01% 4344